Novel transmembrane protein 126A (TMEM126A) couples with CD137L reverse signals in myeloid cells.

Members of the TNF family can promote signals in myeloid cells and both positively and negatively regulate the production of pro-inflammatory cytokines depending on the target myeloid cell type. Using the yeast-two hybrid system, we identified transmembrane protein 126A (TMEM126A) as a binding partner for CD137L (4-1BB ligand). We found that TMEM126A associated and co-localized with CD137L in a mouse macrophage cell line and knockdown of TMEM126A with siRNA abolished the CD137L-induced tyrosine phosphorylation as well as the up-regulation of M-CSF, IL-1β and TN-C expressions. Knockdown of TMEM126A also blocked the down-regulation of IL-1β and IL-6 expressions induced by CD137L in thioglycollate-elicited primary peritoneal macrophages. Knockdown of TMEM126A by stable retroviral TMEM126A shRNA transduction also abolished CD137L-induced tyrosine phosphorylation and cell adherence. These findings identify a novel molecule that bridges TNF family cytokines and pro-inflammatory cytokine secretion in myeloid cells. Copyright © 2012 Elsevier Inc. All rights reserved.

Citation

Jun-Sang Bae, Joong-Kook Choi, Ji-Hoi Moon, Eun-Cheol Kim, Michael Croft, Hyeon-Woo Lee. Novel transmembrane protein 126A (TMEM126A) couples with CD137L reverse signals in myeloid cells. Cellular signalling. 2012 Dec;24(12):2227-36

Mesh Tags

Substances

PMID: 22885069

search → result